Serous detachment of the retina

Retina

Volumn 23, Issue 6, 2003, Pages 820-846

  Spaide, Richard F ^a   Goldbaum, Mauro ^b   Wong, Doric W K ^c   Tang, Kong Chan ^d   Iida, Tomohiro ^e  

^a VITREOUS RETINA MACULA CONSULTANTS OF NEW YORK   (United States)

^b Hosp Gen de Itapercerica de Serra   (Brazil)

^c SINGAPORE NATIONAL EYE CENTRE   (Singapore)

^d Orange Eye Centre   (Australia)

^e FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BENZOPORPHYRIN DERIVATIVE; CORTICOSTEROID; CYCLOSPORIN; CYTOKINE; FIBRINOGEN; IMMUNOSUPPRESSIVE AGENT; MELANIN; PROTEIN; PROTON; VASCULOTROPIN;

BLOOD EYE BARRIER; BLOOD FLOW VELOCITY; BLOOD VESSEL PERMEABILITY; CHOROID DISEASE; CHOROID MELANOMA; CHOROID TUMOR; CHOROIDAL VASCULAR HYPERPERMEABILITY; CONGENITAL BLOOD VESSEL MALFORMATION; CRYOTHERAPY; DESMOSOME; DIFFERENTIAL DIAGNOSIS; DISSEMINATED INTRAVASCULAR CLOTTING; EFFUSION; EXUDATIVE RETINITIS; FLUID FLOW; FLUORESCENCE; FLUORESCENCE ANGIOGRAPHY; HEALTH; HEMANGIOMA; HEMANGIOMATOSIS; HUMAN; HYDRODYNAMICS; HYDROSTATIC PRESSURE; LASER; LASER COAGULATION; MALIGNANT HYPERTENSION; MICROVASCULATURE; NEVUS; OSMOTIC PRESSURE; PATHOPHYSIOLOGY; PHOTODYNAMIC THERAPY; PIGMENT EPITHELIUM; PIGMENTATION; PREECLAMPSIA; RADIATION INJURY; RETINA DETACHMENT; RETINA VEIN; RETINOBLASTOMA; REVIEW; SCLERA; SCLERITIS; SCLEROTOMY; SEROSA; STURGE WEBER SYNDROME; SUBRETINAL FLUID; SUBRETINAL NEOVASCULARIZATION; SYNDROME; THEORETICAL MODEL; THROMBOSIS; THROMBOTIC THROMBOCYTOPENIC PURPURA; TUMOR RECURRENCE; UVEA DISEASE; UVEAL EFFUSION SYNDROME; VOGT KOYANAGI SYNDROME;

BODY FLUIDS; EXUDATES AND TRANSUDATES; HUMANS; RETINA; RETINAL DETACHMENT;

EID: 0346731199     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-200312000-00013     Document Type: Review

References (163)

1. Spaide RF, Yannuzzi LA. Mechanisms maintaining retinal and pigment epithelial attachment: a theoretical framework with practical considerations. In: Marmor MF, ed. The retinal pigment epithelium. Function and disease. New York: Oxford Press, 1998:439-455.
2. Kirchhof B, Ryan SJ. Differential permeance of retina and retinal pigment epithelium to water: implications for retinal adhesion. Int Ophthalmol 1993;17:19-22.
3. Chihara E, Nao I-N. Resorption of subretinal fluid by transepithelial flow of the retinal pigment epithelium. Graefes Arch Clin Exp Ophthalmol 1985;223:202-204.
4. Pederson JE, Cantrill HL. Experimental retinal detachment. V. Fluid movement through the retinal hole. Arch Ophthalmol 1984;102:136-139.
5. Pederson JE. Fluid physiology of the subretinal space. In: Ryan SJ, ed. Retina. St. Louis: Mosby, 1994:1955-1967.
6. Fisher SK, Steinberg RH. Origin and organization of pigment epithelial apical projections to cones in cat retina. J Cell Biol 1982;206:131-145.
7. Berman ER. Mucopolysaccharides (glycosaminoglycans) of the retina: identification, distribution, and possible biological role. Mod Prob Ophthalmol 1969;8:5-31.
8. Adler AJ, Kluznik KM. Proteins and glycoproteins of the bovine interphotoreceptor matrix: composition and fractionation. Exp Eye Res 1985;34:423-434.
9. Hageman GS, Marmor MF, Yao XY, Johnson LV. The interphotoreceptor matrix mediates primate retinal adhesion. Arch Ophthalmol 1995; 113:655-660.
10. Yao XY, Hageman GS, Marmor MF. Recovery of retinal adhesion after enzymatic perturbation of the interphotoreceptor matrix. Invest Ophthalmol Vis Sci 1992;33:498-503,
11. Lazarus HS, Hageman GS. Xyloside-induced disruption of interphotoreceptor matrix proteoglycans results in retinal detachment. Invest Ophthalmol Vis Sci 1992;33:364-376.
12. Hudspeth AJ, Yee AG. The intercellular junctional complexes of retinal pigment epithelia. Invest Ophthalmol Vis Sci 1973;12:354-365.
13. Negi A, Marmor MF. The resorption of subretinal fluid after diffuse damage to the retinal pigment epithelium. Invest Ophthalmol Vis Sci 1983;24:1475-1479.
14. Negi A, Marmor MF. Experimental serous retinal detachment and focal pigment epithelial damage. Arch Ophthalmol 1984;102:445-449.
15. Miller SS, Edelman JL. Active ion transport pathways in the bovine retinal pigment epithelium. J Physiol (Lond) 1990; 424:283-300.
16. Joseph DP, Miller SS. Apical and basal membrane ion transport mechanisms in bovine retinal pigment epithelium. J Physiol (Lond) 1991;435:439-463.
17. - co-transport in the retinal pigment epithelium. Acta Ophthalmol (Copenh) 1991;69:496-504.
18. Adorante JS, Miller SS. Potassium-dependent volume regulation in retinal pigment epithelium is mediated by Na-, K, Cl cotransport. J Gen Physiol 1990;96:1153-1176.
19. Burke JM, McKay BS. In vitro aging of bovine and human retinal pigment epithelium: number and activity of the Na/K ATPase pump. Exp Eye Res 1993;57:51-57.
20. Lin H, Kenyon E, Miller SS. Na-dependent pH regulatory mechanisms in native human retinal pigment epithelium. Invest Ophthalmol Vis Sci 1992;33:3528-3538.
21. Negi A, Marmor MF. Quantitative estimation of metabolic transport of subretinal fluid. Invest Ophthalmol Vis Sci 1986;27:1564-1568.
22. Marmor MF, Maack T. Enhancement of retinal adhesion and subretinal fluid resorption by acetazolamide. Invest Ophthalmol Vis Sci 1982;23:121-124.
23. Marmor MF, Abdul-Rahim AS, Cohen DS. The effect of metabolic inhibitors on retinal adhesion and subretinal fluid resorption. Invest Ophthalmol Vis Sci 1980;19:893-903.
24. Ernest JT. Choroidal circulation. In: Ryan SJ, ed. Retina. St. Louis: Mosby, 1994:76-80.
25. Nakanome Y, Karita K, Izumi H, Tamai M, Okabe H, Abe S. Experimental research on choroidal circulation. 2. Choroidal blood flow increase elicited by electrical stimulation of parasympathetic nerve behind the eyeball in the cat. Nippon Ganka Gakkai Zasshi 1994;98:962-967.
26. Shih YF, Fitzgerald ME, Reiner A. Effect of choroidal and ciliary nerve transection on choroidal blood flow, retinal health, and ocular enlargement. Vis Neurosci 1993;10:969-979.
27. Fitzgerald ME, Vana BA, Reiner A. Control of choroidal blood flow by the nucleus of Edinger-Westphal in pigeons: a laser Doppler study. Invest Ophthalmol Vis Sci 1990; 31: 2483-2492.
28. Kiel JW. Choroidal myogenic autoregulation and intraocular pressure. Exp Eye Res 1994;58:529-543.
29. Lopez-Costa JJ, Goldstein J, Mallo G, Saavedra JP. NADPH-diaphorase distribution in the choroid after continuous illumination. Neuroreport 1995;6:361-364.
30. Mann RM, Riva CE, Stone RA, Barnes GE, Cranstoun SD. Nitric oxide and choroidal blood flow regulation. Invest Ophthalmol Vis Sci 1995;36:925-930.
31. Yoshioka H, Katsume Y. Experimental central serous chorioretinopathy. III: ultrastructural findings. Jpn J Ophthalmol 1982;26:397-409.
32. Yoshioka H, Katsume Y, Akune H. Experimental central serous chorioretinopathy in monkey eyes: fluorescein angiographic findings. Ophthalmologica 1982;185:168-178.
33. Pino RM. Restriction to endogenous plasma proteins by a fenestrated capillary endothelium: an ultrastructural immunocytochemical study of the choriocapillary endothelium. Am J Anat 1985;172:279.
34. Toris CB, Pederson JE. Experimental retinal detachment. VII. Intravenous horseradish peroxidase diffusion across the blood-retinal barrier. Arch Ophthalmol 1984;102:752.
35. Smith RS. Rudt LA. Ocular vascular and epithelial barrier to microperoxidase. Invest Ophthalmol Vis Sci 1975;14:556.
36. Brockhurst RJ. Nanophthalmos with uveal effusion: a new clinical entity. Arch Ophthalmol 1975;93:1289.
37. Gass JDM. Uveal effusion syndrome: a new hypothesis concerning pathogenesis and technique of surgical treatment. Trans Am Ophthalmol Soc 1983;81:246.
38. Stewart DH 3rd, Streeten BW, Brockhurst RJ, Anderson DR, Hirose T, Gass DM. Abnormal scleral collagen in nanophthalmos. An ultrastructural study. Arch Ophthalmol 1991;109:1017-1025.
39. Yue BY, Kurosawa A, Duvall J, Goldberg MF, Tso MO, Sugar J. Nanophthalmic sclera. Fibronectin studies. Ophthalmology 1988;95:56-60.
40. Ward RC, Gragoudas ES, Pon DM, Albert DM. Abnormal scleral findings in uveal effusion syndrome. Am J Ophthalmol 1988;106:139-146.
41. Kawamura M, Tajima S, Azuma N, Katsura H, Akiyama K. Biochemical studies of glycosaminoglycans in nanophthalmic sclera. Graefes Arch Clin Exp Ophthalmol 1995;233: 58-62.
42. Gelber GS, Schatz H. Loss of vision due to central serous chorioretinopathy following psychological stress. Am J Psychiatry 1987;144:46-50.
43. Yannuzzi LA. Type-A behavior and central serous chorioretinopathy. Retina 1987;7:111.
44. Polak BC, Baarasma GS, Snyers B. Diffuse retinal pigment epitheliopathy complicating systemic corticosteroid treatment. Br J Ophthalmol 1995;79:922-925.
45. Gass JD, Little H. Bilateral bullous exudative retinal detachment complicating idiopathic central serous chorioretinopathy during systemic corticosteroid therapy. Ophthalmology 1995; 102:737-747.
46. Gass JDM. Central serous chorioretinopathy and white subretinal exudation during pregnancy. Arch Ophthalmol 1991; 109:677-681.
47. Tittl MK, Spaide RF, Wong D, et al. Systemic and ocular findings in central serous chorioretinopathy. Am J Ophthalmol 1999;128:63-68.
48. Spaide RF, Hall L, Haas A, et al. Indocyanine green video-angiography of older adults with central serous chorioretinopathy. Retina 1996;16:203-213.
49. Spaide RF, Campeas L, Haas A, et al. Central serous chorioretinopathy in younger and older adults. Ophthalmology 1996;103:2070-2080.
50. Jalkh AE, Jabbour N, Avila MP, Trempe CL, Schepens CL. Retinal pigment epithelium decompensation. I. Clinical features and natural course. Ophthalmology 1984;91:1544-1548.
51. de Venecia G. Fluorescein angiographic smoke stack [case presentation]. Verhoeff Society Meeting, Washington, DC, April 24-25, 1982. [Quoted from Gass JDM. Stereoscopic atlas of macular diseases. St. Louis: CV Mosby, 1987:56-57.]
52. de Venecia G. Fluorescein angiographic smoke stack [case presentation]. Verhoeff Society Meeting, Washington, DC, April 24-25, 1982. [Quoted from Gass JDM. Stereoscopic atlas of macular diseases. St. Louis: CV Mosby, 1987:56-57.]
53. Ie D, Yannuzzi LA, Spaide RF, Rabb MF, Blair NP, Daily MJ. Subretinal exudative deposits in central serous chorioretinopathy. Br J Ophthalmol 1993;77:349-353.
54. Spitznas M, Huke J. Number, shape, and topography of leakage points in acute type I central serous retinopathy. Graefes Arch Clin Exp Ophthalmol 1987;225:438-440.
55. Shimizu K, Tobari I. Central serous retinopathy dynamics of subretinal fluid. Mod Probl Ophthalmol 1971;9:152.
56. Yannuzzi LA, Shakin JL, Fisher YL, Altomonte MA. Peripheral retinal detachments and retinal pigment epithelial atrophic tracts secondary to central serous pigment epitheliopathy. Ophthalmology 1984;91:1554-1572.
57. Levine R, Brucker AJ, Robinson F. Long-term follow-up of idiopathic central serous chorioretinopathy by fluorescein angiography. Ophthalmology 1989;96:854-859.
58. Prunte C, Flammer J. Choroidal capillary and venous congestion in central serous chorioretinopathy. Am J Ophthalmol 1996;121:26-34.
59. Iida T, Kishi S, Hagimura N, Shimizu K. Persistent and bilateral choroidal vascular abnormalities in central serous chorioretinopathy. Retina 1999;19:508-512.
60. Hayashi K, Hasegawa Y, Tokoro T. Indocyanine green angiography of central serous chorioretinopathy. Int Ophthalmol 1986;9:37-41.
61. Iida T, Spaide RF, Haas A, et al. Leopard-Spot pattern of yellowish subretinal deposits in central serous chorioretinopathy. Arch Ophthalmol 2002;120:37-42.
62. Guyer DR, Yannuzzi LA, Slakter JS, Sorenson JA, Ho A, Orlock D. Digital indocyanine green videoangiography of central serous chorioretinopathy. Arch Ophthalmol 1994; 112:1057-1062.
63. Piccolino FC, Borgia L. Central serous chorioretinopathy and indocyanine green angiography. Retina 1994;14:231-242.
64. Piccolino FC, Borgia L, Zinicola E, Zingirian M. Indocyanine green angiographic findings in central serous chorioretinopathy. Eye 1995;9(pt 3):324-332.
65. Spaide RF, Orlock D, Ciardella A, et al. Wide-angle indocyanine green angiography. Retina 1998;18:44-49.
66. Marmor MF. New hypotheses on the pathogenesis and treatment of serous retinal detachment. Graefes Arch Clin Exp Ophthalmol 1988;226:548-552.
67. Spitznas M. Pathogenesis of central serous retinopathy: a new working hypothesis. Graefes Arch Clin Exp Ophthalmol 1986;224:321-324.
68. Yoshioka H, Sugita T, Nagayoski K. Fluorescein angiography findings in experimental retinopathy produced by intravenous adrenaline injection. Folia Ophthalmol Jpn 1970;21: 648-652.
69. Miki T, Sunada I, Higaki T. Studies on chorioretinitis induced in rabbits by stress (repeated administration of epinephrine). Acta Soc Ophthalmol Jpn 1972;75:1037-1045.
70. Warren JB, Loi RK, Coughlan ML. Involvement of nitric oxide synthase in the delayed vasodilator response to ultraviolet light irradiation of rat skin in vivo. Br J Pharmacol 1993; 109:802-806.
71. Ficker L, Vafidis G, While A, Leaver P. Long-term follow-up of a prospective trial of argon laser photocoagulation in the treatment of central serous retinopathy. Br J Ophthalmol 1988;72:829-834.
72. Gilbert CM, Owens SL, Smith PD, Fine SL. Long term follow up of central serous chorioretinopathy. Br J Ophthalmol 1984;68:815-820.
73. Leaver P, Williams C. Argon laser photocoagulation in the treatment of central serous retinopathy. Br J Ophthalmol 1979;63:674-677.
74. Brancato R, Scialdone A, Pece A, Coscas G, Binaghi M. Eight-year follow-up of central serous chorioretinopathy with and without laser treatment. Graefes Arch Clin Exp Ophthalmol 1987;225:166-168.
75. Yap EY, Robertson DM. The long-term outcome of central serous chorioretinopathy. Arch Ophthalmol 1996; 114:689-692.
76. Burumcek E, Mudum A, Karacorlu S, Arslan MO. Laser photocoagulation for persistent central serous chorioretinopathy: results of long-term follow-up. Ophthalmology 1997;104:616-622.
77. Matsunaga H, Nangoh K, Uyama M, Nanbu H, Fujiseki Y, Takahashi K. Occurrence of choroidal neovascularization following photocoagulation treatment for central serous retinopathy. Nippon Ganka Gakkai Zasshi 1995;99:460-468.
78. Witschel H, Font RL. Hemangioma of the choroid. A clinicopathologic study of 71 cases and a review of the literatute. Surv Ophthalmol 1976;20:415-431.
79. Phelps CD. The pathogenesis of glaucoma in Sturge-Weber syndrome. Trans Am Acad Ophthalmol Otolaryngol 1978; 85:276-286.
80. Augsburger JJ, Shields JA, Moffat HP. Circumscribed choroidal hemangiomas: long term visual prognosis. Retina 1981; 1:56-61.
81. Zografos L, Bercher L, Chamot L, Gailloud C, Raimondi S, Egger E. Cobalt-60 treatment of choroidal hemangiomas. Am J Ophthalmol 1996;121:190-199.
82. Ruby AJ, Jampol LM, Goldberg MF, Schroeder R, Anderson-Nelson S. Choroidal neovascularization associated with choroidal hemangiomas. Arch Ophthalmol 1992;110: 658-661.
83. Spraul CW, Kim D, Fineberg E, Grossniklaus HE. Mushroom-shaped choroidal hemangioma. Am J Ophthalmol 1996;122:434-436.
84. Norton EWD, Gutman F. Fluorescein angiography and hemangiomas of the choroid. Arch Ophthalmol 1967;78: 121-125.
85. Gass JDM. Stereoscopic atlas of macular diseases: diagnosis and treatment. 4th ed. St. Louis: CV Mosby, 1997:208-214.
86. Piccolino FC, Borgia L, Zinicola E. Indocyanine green angiography of circumscribed choroidal hemangiomas. Retina 1996;16:19-28.
87. Madreperla SA, Hungerford JL, Plowman PN, Laganowski HC, Gregory PT. Choroidal hemangiomas: visual and anatomic results of treatment by photocoagulation or radiation therapy. Ophthalmology 1997;104:1773-1778; discussion 1779.
88. Scott TA, Augsburger JJ, Brady LW, Hernandez C, Woodleigh R. Low dose ocular irradiation for diffuse choroidal hemangiomas associated with bullous nonrhegmatogenous retinal detachment. Retina 1991;11:389-393.
89. Hannouche D, Frau E, Desjardins L, Cassoux N, Habrand JL, Offret H. Efficacy of proton therapy in circumscribed choroidal hemangiomas associated with serious retinal detachment. Ophthalmology 1997;104:1780-1784.
90. Barbazetto I, Schmidt-Erfurth U. Photodynamic therapy of choroidal hemangioma: two case reports. Graefes Arch Clin Exp Ophthalmol 2000;238:214-221.
91. Shields JA, Shields CL. Posterior uveal melanoma. Clinical and pathological features. In: Intraocular tumors: a text and atlas. Philadelphia: Saunders, 1992: 117-136.
92. Shields JA, Shields CL. Diagnostic approaches to posterior uveal melanomas. In: Intraocular tumors: a text and atlas. Philadelphia: Saunders, 1992:155-169.
93. Flindall RJ, Gass LDM. A histopathologic fluorescein angiographic correlative study of malignant melanomas of the choroid. Can J Ophthalmol 1971;6:258-267.
94. Edwards WC, Layden WE, McDonald R. Fluorescein angiography of malignant melanoma of the choroid. Am J Ophthalmol 1969;68:797-808.
95. Shields JA, Shields CL, De Potter P. Patterns of indocyanine green videoangiography of choroidal tumors. Br J Ophthalmol 1995;79:237-245.
96. Shields CL. Clinical evaluation of choroidal tumors. In: Yannuzzi LA, Flower RW, Slakter JS, eds. Indocyanine green angiography. St. Louis: Mosby, 1997:279-295.
97. Mueller AJ, Bartsch DU, Folberg R, et al. Imaging the microvasculature of choroidal melanomas with confocal indocyanine green scanning laser ophthalmoscopy. Arch Ophthalmol 1998;116:31-39.
98. Vinores SA, Kuchle M, Mahlow J, Chiu C, Green WR, Campochiaro PA. Blood-ocular barrier breakdown is eyes with ocular melanoma. A potential role for vascular endothelial growth factor/vascular permeability factor. Am J Pathol 1995;147:1289-1297.
99. Folberg R, Hendrix MJ, Maniotis AJ. Vasculogenic mimicry and tumor angiogenesis. Am J Pathol 2000;156:361-381.
100. Rofstad EK, Tunheim SH, Mathiesen B, et al. Pulmonary and lymph node metastasis is associated with primary tumor interstitial fluid pressure in human melanoma xenografts. Cancer Res 2002;62:661-664.
101. Nelson CC, Hertzberg BS, Klintworth GK. A histopathologic study of 716 unselected eyes in patients with cancer at the time of death. Am J Ophthalmol 1983;95:788-793.
102. Bloch RS, Gartner S. The incidence of ocular metastatic carcinoma. Arch Ophthalmol 1971;85:673-675.
103. Shields CL, Shields JA, Gross N, et al. Survey of 520 uveal metastases. Ophthalmology 1997;104:1265-1276.
104. Shields JA, Shields CL. Metastatic tumors to the intraocular structures. In: Intraocular tumors: a text and atlas. Philadelphia: Saunders, 1992:207-238.
105. Davis DL, Robertson DM. Fluorescein angiography of metastatic choroidal tumors. Arch Ophthalmol 1973;89:97-99.
106. Uyama M, Takahashi K, Kozaki J, et al. Uveal effusion syndrome: clinical features, surgical treatment, histologic examination of the sclera, and pathophysiology. Ophthalmology 2000;107:441-449.
107. Brockhurst RJ. Vortex vein decompression for nanophthalmic uveal effusion. Arch Ophthalmol 1980;98:1987-1990.
108. Gass JD. Uveal effusion syndrome. A new hypothesis concerning pathogenesis and technique of surgical treatment. Retina 1983;3:159-163.
109. Rao NA, Moorthy RS, Inomata H. Vogt-Koyanagi-Harada syndrome. Int Ophthalmol Clin 1995;35:69-86.
110. Read RW, Holland GN, Rao NA, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 2001;131:647-652.
111. Davis JL, Mittal KK, Freidlin V, et al. HLA associations and ancestry in Vogt-Koyanagi-Harada disease and sympathetic ophthalmia. Ophthalmology 1990;97:1137-1142.
112. Murakami S, Inaba Y, Mochizuki M, Nakajima A, Urayama A. A nationwide survey on the occurrence of Vogt-Koyanagi-Harada disease in Japan. Jpn J Ophthalmol 1994;38: 208-213.
113. Norose K, Yano A, Aosai F, Segawa K. Immunologic analysis of cerebrospinal fluid lymphocytes in Vogt-Koyanagi-Harada disease. Invest Ophthalmol Vis Sci 1990;31: 1210-1216.
114. Nussenblat RB, Palestine AG. The Vogt-Koyanagi-Harada syndrome (uveomeningitic syndrome). In: Ryan SJ, ed. Retina. 2nd ed. St. Louis: Mosby, 1994:1737-1743.
115. Inomata H, Rao NA. Depigmented atrophic lesions in sunset glow fundi of Vogt-Koyanagi-Harada disease. Am J Ophthalmol 2001;131:607-614.
116. Forster DJ, Cano MR, Green RL, Rao NA. Echographic features of the Vogt-Koyanagi-Harada syndrome. Arch Ophthalmol 1990;108:1421-1426.
117. Matsunaga H, Matsubara T, Fukushima I, Uyama M. Indocyanine green fluorescence angiography in Harada disease. Nippon Ganka Gakkai Zasshi 1994;98:852-857.
118. Yuzawa M, Kawamura A, Matsui M. Indocyanine green video-angiographic findings in Harada's disease. Jpn J Ophthalmol 1993;37:456-466.
119. Edamitsu S, Matsukawa A, Ohkawara S, Takagi K, Nariuchi H, Yoshinaga M. Role of TNF alpha, IL-1, and IL-Ira in the mediation of leukocyte infiltration and increased vascular permeability in rabbits with LPS-induced pleurisy. Clin Immunol Immunopathol 1995;75:68-74.
120. Green K, Paterson CA, Cheeks L, Slagle T, Jay WM, Aziz MZ. Ocular blood flow and vascular permeability in endotoxin-induced inflammation. Ophthalmic Res 990;22:287-294.
121. Sanders MD, Graham EM. Retinal vasculitis. Postgrad Med J 1988;64:488-496.
122. Melton RC, Spaide, RF. Visual problems as a presenting sign for thrombotic thrombocytopenic purpura. Retina 1996; 16:78-80.
123. Cogan DG. Ocular involvement in disseminated intravascular coagulopathy. Arch Ophthalmol 1975;93:1-8.
124. Valluri S, Adelberg DA, Curtis RS, Olk RJ. Diagnostic indocyanine green angiography in preeclampsia. Am J Ophthalmol 1996;122:672-677.
125. Iida T, Hagimura N, Otani T, Ikeda F, Muraoka K. Choroidal vascular lesions in serous retinal detachment viewed with indocyanine green angiography. J Jpn Ophthalmol Soc 1996;100:817-824.
126. Suto K, Iida T, Hagimura N, Kishi S. Indocyanine green angiographic findings of hypertensive choroidopathy. Jpn J Clin Ophthalmol 2001;55:146-148.
127. MacCumber MW, Flower RW, Langham ME. Ischemic hypertensive choroidopathy. Fluorescein angiography, indocyanine green videoangiography, and measurement of pulsatile blood flow. Arch Ophthalmol 1993;111:704-705.
128. Karsdorp N, Elderson A, Wittebol-Post D, et al. Von Hippel-Lindau disease: new strategies in early detection and treatment. Am J Med 1994;97:158-168.
129. Maher ER, Yates JRW, Harries, et al. Clinical features and natural history of von Hippel-Lindau disease. Q J Med 1990;77:1151-1163.
130. Latif F, Tory K, Gnarra J, et al. Identification of the von Hippel-Lindau tumor suppressor gene. Science 1993;260: 1317-1320.
131. Balazs E, Berta A, Rozsa L, Kolozsvari L, Rigo G. Hemodynamic changes after ruthenium irradiation of Hippel's angiomatosis. Ophthalmologica 1990;200:128-132.
132. Nicholson DH, Anderson LS, Blodi C. Rhegmatogenous retinal detachment in angiomatosis retinae. Am J Ophthalmol 1986;101:187-189.
133. Machemer R, Williams JM Sr. Pathogenesis and therapy of traction detachment in various retinal vascular diseases. Am J Ophthalmol 1988;105:170-181.
134. Goldberg MF, Koenig S. Argon laser treatment of von Hippel-Lindau retinal angiomas: I. Clinical and angiographic findings. Arch Ophthalmol 1974;92:121-125.
135. Blodi CF, Russell SR, Pulido JS, Folk JC. Direct and feeder vessel photocoagulation of retinal angiomas with dye yellow laser. Ophthalmolol 1990;97:791-797.
136. Rodriguez-Coleman H, Spaide RF, Yannuzzi LA. Treatment of angiomatous lesions of the retina with photodynamic therapy. Retina (in press).
137. Schmidt-Erfurth UM, Kusserow C, Barbazetto IA, Laqua H. Benefits and complications of photodynamic therapy of papillary capillary hemangiomas. Ophthalmology 2002;109: 1256-1266.
138. Kubota T, Kurihara K, Ishibashi T, Inomata H. Proliferative vitreoretinopathy in Coats' disease. Clinicohistopathological case report. Ophthalmologica 1995;209:44-46.
139. Chang M, Mclean IW, Merritt JC. Coats' disease: a study of 62 histopathologically confirmed cases. J Pediatr Ophthalmol Strabismus 1984;21:163-168.
140. Yoshizumi MO, Kreiger AE, Lewis H, et al. Vitrectomy techniques in late-stage Coats' like exudative retinal detachment. Doc Ophthalmol 1995;90:387-394.
141. Christoffersen N, Sander B, Larsen M. Precipitation of hard exudate after resorption of intraretinal edema after treatment of retinal branch vein occlusion. Am J Ophthalmol 1998; 126:454-456.
142. Schatz H, Yannuzzi L, Stransky TJ. Retinal detachment secondary to branch vein occlusion: part I. Ann Ophthalmol 1976;8:1437-1452.
143. Schatz H, Yannuzzi L, Stransky TJ. Retinal detachment secondary to branch vein occlusion: Part II. Ann Ophthalmol 1976;8:1461-1471.
144. Parodi M, Isola V. Branch retinal vein occlusion and exudative retinal detachment: Pathological aspects. Ophthalmologica 1994;208:29-31.
145. Weinberg D, Jampol LM, Schatz H, Brady K. Exudative retinal detachment following central and hemicentral retinal vein occlusions. Arch Ophthalmol 1990;108:271-275.
146. Spaide RF, Lee JK, Klancnik JM, Gross NE. Optical coherence tomography of branch retinal vein occlusion. Retina (in press).
147. Vinores SA, Youssri AI, Luna JD, et al. Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease. Histol Histopathol 1997;12:99-109.
148. Ito Y, Nakano M, Kyu N, Takeuchi M. Frosted-branch angiitis in a child. Jpn J Ophthalmol 1976;30:797.
149. Yamane S, Nishiuchi T, Nakagawa Y, Iwase T, Hama M. A case of frosted-branch angiitis of the retina. Folia Ophthalmol Jpn 1985;6:1822.
150. Kleiner R, Kaplan HJ, Shakin JL, Yannuzzi LA, Crosswell HH, McLean WC. Acute frosted retinal periphlebitis. Am J Ophthalmol 1988;106:27.
151. Sugin SL, Henderly DE, Friedman SM, Jampol LM, Doyle JW. Unilateral frosted branch angiitis. Am J Ophthalmol 1991;111:682.
152. Vander JF, Masciulli L. Unilateral frosted branch angiitis. Am J Ophthalmol 1991;112:477.
153. Hamed LM, Fang EN, Fanous MM, Mames R, Friedman S. Frosted branch angiitis: the role of systemic corticosteroids. J Pediatr Ophthalmol Strabismus 1992;29:312-313.
154. Tanikawa H, Akimoto S, Honda M, et al. Indocyanine green video angiographic findings of frosted branch angitis in a child. Nippon Ganka Gakkai Zasshi 1998;102:399-404.
155. Borkowski LM, Jampol LM. Frosted branch angiitis complicated by retinal neovascularization. Retina 1999;19:454-455.
156. Lobes LA, Grand MG. Subretinal lesions following scleral buckling procedure. Arch Ophthalmol 1980;98:680-683.
157. Avins LR, Hilton GF. Lesions simulating serous detachment of the pigment epithelium. Occurrence after retinal detachment surgery. Arch Ophthalmol 1980;98:1427-1429.
158. Piguet B, Bovey E, Zografos L. Subretinal lesions following a scleral buckling procedure. Ophthalmologica 1997;211: 112-114.
159. Kaga T, Fonseca RA, Dantas MA, et al. Optical coherence tomography of bleb-like subretinal lesions after retinal reattachment surgery. Am J Ophthalmol 2001;132:120-121.
160. Wolfensberger TJ, Gonvers M. Optical coherence tomography in the evaluation of incomplete visual acuity recovery after macula-off retinal detachments. Graefes Arch Clin Exp Ophthalmol 2002;240:85-89.
161. Machemer R. Experimental retinal detachment in the owl monkey: IV. The reattached retina. Am J Ophthalmol 1968; 66:1075-1091.
162. Takeuchi A, Kricorian G, Marmor MF. Albumin movement out of the subretinal space after experimental retinal detachment. Invest Ophthalmol Vis Sci 1995;36:1298-1305.
163. Ho AC, Benson WE, Wong J. Unusual immunogammopathy maculopathy. Ophthalmology 2000;107:1099-1103.